ARTICLE | Company News
Theralpha SAS neurology news
September 12, 2011 7:00 AM UTC
Theralpha launched the R&D consortium SubAlgic, which received €2.6 million ($3.6 million) to fund three years of preclinical and clinical development of Theralpha's THA903. The small peptide derivat...